Cannara Biotech Inc. (TSX:LOVE)
2.020
+0.015 (0.75%)
Nov 19, 2026, 4:00 PM EST
Cannara Biotech Market Cap
Cannara Biotech has a market cap or net worth of CAD 199.41 million as of November 19, 2026. It is the 22,528th most valuable company in the world and the 548th biggest in Canada. Its market cap has increased by 31.33% in one year.
Market Cap
199.41M
Enterprise Value
214.60M
Revenue
117.33M
Global Rank
Country Rank
#548 Canada
PE Ratio
18.37
ChartMarket Cap Chart
Since January 14, 2019, Cannara Biotech's market cap has decreased from 211.62M to 199.41M, a decrease of -5.77%. That is a compound annual growth rate of -0.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2026 | 199.41M | 20.65% |
| Dec 31, 2025 | 165.28M | 148.11% |
| Dec 31, 2024 | 66.61M | -10.84% |
| Dec 29, 2023 | 74.72M | -10.37% |
| Dec 30, 2022 | 83.36M | -29.55% |
| Dec 31, 2021 | 118.32M | 100.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cipher Pharmaceuticals | 339.04M |
| Canopy Growth | 325.98M |
| Cresco Labs | 252.25M |
| BioSyent | 204.69M |
| Medexus Pharmaceuticals | 187.12M |
| TerrAscend | 176.08M |
| Cardiol Therapeutics | 162.38M |
| Organigram Global | 143.83M |